Carbon Ion RT for Locally Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response
- Status
- RECRUITING
- Phase
- NA
CIRcular and Non-coding RNAs as Clinically USeful Biomarkers in Pancreaticobiliary Cancers
- Status
- UNKNOWN
- Phase
- N/A
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
- Status
- AVAILABLE
- Phase
- N/A
CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer
- Status
- COMPLETED
- Phase
- NA
'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
- Status
- COMPLETED
- Phase
- N/A
Biomarkers of Pancreatic Cancer and New Way to Detection
- Status
- UNKNOWN
- Phase
- N/A
Supportive Oncology Care At Home RCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition
- Status
- COMPLETED
- Phase
- PHASE1
Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
OMT-111 for Terminal Stage Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- NA
Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy
- Status
- TERMINATED
- Phase
- N/A
Training Endoscopists to Perform On-site Rapid Cytological Evaluation for EUS-FNA of Solid Pancreatic Lesions
- Status
- UNKNOWN
- Phase
- N/A
A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)
- Status
- TERMINATED
- Phase
- PHASE2